Blaine, J., Chonchol, M. & Levi, M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin. J. Am. Soc. Nephrol. 10, 1257–1272 (2015).
Eisner, D., Neher, E., Taschenberger, H. & Smith, G. Physiology of intracellular calcium buffering. Physiol. Rev. 103, 2767–2845 (2023).
Moor, M. B. & Bonny, O. Ways of calcium reabsorption in the kidney. Am. J. Physiol. Renal Physiol. 310, F1337–F1350 (2016).
Jeon, U. S. Kidney and calcium homeostasis. Electrolyte Blood Press. 6, 68–76 (2008).
Alexander, R. T., Cordat, E., Chambrey, R., Dimke, H. & Eladari, D. Acidosis and urinary calcium excretion: insights from genetic disorders. J. Am. Soc. Nephrol. 27, 3511–3520 (2016).
Peacock, M. Calcium metabolism in health and disease. Clin. J. Am. Soc. Nephrol. 5, S23–S30 (2010).
Bosman, A. et al. Sexual dimorphisms in serum calcium and phosphate concentrations in the Rotterdam Study. Sci. Rep. 13, 8310 (2023).
Meoli, L. & Gunzel, D. The role of claudins in homeostasis. Nat. Rev. Nephrol. 19, 587–603 (2023).
Tinawi, M. Disorders of calcium metabolism: hypocalcemia and hypercalcemia. Cureus 13, e12420 (2021).
Alexander, R. T., Fuster, D. G. & Dimke, H. Mechanisms underlying calcium nephrolithiasis. Annu. Rev. Physiol. 84, 559–583 (2022).
Alexander, R. T. Kidney stones, hypercalciuria, and recent insights into proximal tubule calcium reabsorption. Curr. Opin. Nephrol. Hypertens. 32, 359–365 (2023).
Pan, W. et al. The epithelial sodium/proton exchanger, NHE3, is necessary for renal and intestinal calcium (re)absorption. Am. J. Physiol. Renal Physiol. 302, F943–F956 (2012).
Beggs, M. R. et al. Claudin-2 and claudin-12 form independent, complementary pores required to maintain calcium homeostasis. Proc. Natl Acad. Sci. USA 118, e2111247118 (2021).
Curry, J. N. et al. Claudin-2 deficiency associates with hypercalciuria in mice and human kidney stone disease. J. Clin. Invest. 130, 1948–1960 (2020).
Plain, A. et al. Claudin-12 knockout mice demonstrate reduced proximal tubule calcium permeability. Int. J. Mol. Sci. 21, 2074 (2020).
Breiderhoff, T. et al. Claudin-10a deficiency shifts proximal tubular Cl− permeability to cation selectivity via claudin-2 redistribution. J. Am. Soc. Nephrol. 33, 699–717 (2022).
Rouse, D., Ng, R. C. & Suki, W. N. Calcium transport in the pars recta and thin descending limb of Henle of the rabbit, perfused in vitro. J. Clin. Invest. 65, 37–42 (1980).
Wiebe, S. A. et al. NHE8 attenuates Ca2+ influx into NRK cells and the proximal tubule epithelium. Am. J. Physiol. Renal Physiol. 317, F240–F253 (2019).
Hou, J. et al. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J. Clin. Invest. 118, 619–628 (2008).
Hou, J. et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc. Natl Acad. Sci. USA 106, 15350–15355 (2009).
Simon, D. B. et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 285, 103–106 (1999).
Konrad, M. et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am. J. Hum. Genet. 79, 949–957 (2006).
Zhang, M. et al. TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal. Transduct. Target. Ther. 8, 261 (2023).
Nilius, B. & Owsianik, G. The transient receptor potential family of ion channels. Genome Biol. 12, 218 (2011).
Bacsa, B., Tiapko, O., Stockner, T. & Groschner, K. Mechanisms and significance of Ca2+ entry through TRPC channels. Curr. Opin. Physiol. 17, 25–33 (2020).
Wang, H. et al. TRPC channels: structure, function, regulation and recent advances in small molecular probes. Pharmacol. Ther. 209, 107497 (2020).
Davis, M. J., Earley, S., Li, Y. S. & Chien, S. Vascular mechanotransduction. Physiol. Rev. 103, 1247–1421 (2023).
Nikolaev, Y. A. et al. Mammalian TRP ion channels are insensitive to membrane stretch. J. Cell Sci. 132, jcs238360 (2019).
Goel, M., Sinkins, W. G., Zuo, C. D., Estacion, M. & Schilling, W. P. Identification and localization of TRPC channels in the rat kidney. Am. J. Physiol. Renal Physiol. 290, F1241–F1252 (2006).
Staruschenko, A., Ma, R., Palygin, O. & Dryer, S. E. Ion channels and channelopathies in glomeruli. Physiol. Rev. 103, 787–854 (2023).
Dryer, S. E., Roshanravan, H. & Kim, E. Y. TRPC channels: regulation, dysregulation and contributions to chronic kidney disease. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 1041–1066 (2019).
Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801–1804 (2005).
Reiser, J. et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37, 739–744 (2005).
Zhou, Y. et al. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science 358, 1332–1336 (2017).
Polat, O. K. et al. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5. Kidney Int. 103, 1056–1062 (2023).
Lenoir, O., Huber, T. B. & Tharaux, P. L. From bench to bedside: lessons learned from translational podocyte research. Kidney Int. 103, 1018–1020 (2023).
Hou, X. et al. Transient receptor potential channel 6 knockdown prevents apoptosis of renal tubular epithelial cells upon oxidative stress via autophagy activation. Cell Death Dis. 9, 1015 (2018).
Wu, Y. L. et al. Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho. Kidney Int. 91, 830–841 (2017).
Du, J. et al. Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells. J. Am. Soc. Nephrol. 18, 1437–1445 (2007).
Peng, F. et al. circRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes 70, 603–615 (2021).
Niehof, M. & Borlak, J. HNF4α and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy. Diabetes 57, 1069–1077 (2008).
Khayyat, N. H., Tomilin, V. N., Zaika, O. & Pochynyuk, O. Polymodal roles of TRPC3 channel in the kidney. Channels 14, 257–267 (2020).
Soni, H., Peixoto-Neves, D., Buddington, R. K. & Adebiyi, A. Adenosine A1 receptor-operated calcium entry in renal afferent arterioles is dependent on postnatal maturation of TRPC3 channels. Am. J. Physiol. Renal Physiol. 313, F1216–F1222 (2017).
Ibeh, C. L. et al. Evidence for a regulated Ca2+ entry in proximal tubular cells and its implication in calcium stone formation. J. Cell Sci. 132, jcs.225268 (2019).
Saliba, Y. et al. Evidence of a role for fibroblast transient receptor potential canonical 3 Ca2+ channel in renal fibrosis. J. Am. Soc. Nephrol. 26, 1855–1876 (2015).
Goel, M., Zuo, C. D. & Schilling, W. P. Role of cAMP/PKA signaling cascade in vasopressin-induced trafficking of TRPC3 channels in principal cells of the collecting duct. Am. J. Physiol. Renal Physiol. 298, F988–F996 (2010).
Tomilin, V. N. et al. TRPC3 determines osmosensitive [Ca2+]i signaling in the collecting duct and contributes to urinary concentration. PLoS One 14, e0226381 (2019).
de Baaij, J. H. F. Magnesium reabsorption in the kidney. Am. J. Physiol. Renal Physiol. 324, F227–F244 (2023).
Chubanov, V., Köttgen, M., Touyz, R. M. & Gudermann, T. TRPM channels in health and disease. Nat. Rev. Nephrol. 20, 175–187 (2024).
Schlingmann, K. P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet. 31, 166–170 (2002).
Walder, R. Y. et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet. 31, 171–174 (2002).
Chubanov, V. et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc. Natl Acad. Sci. USA 101, 2894–2899 (2004).
Nadezhdin, K. D. et al. Structural mechanisms of TRPM7 activation and inhibition. Nat. Commun. 14, 2639 (2023).
Fonfria, E. et al. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 143, 186–192 (2004).
Malko, P. & Jiang, L. H. TRPM2 channel-mediated cell death: an important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol. 37, 101755 (2020).
Gao, G. et al. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J. Clin. Invest. 124, 4989–5001 (2014).
Khanahmad, H. et al. Pathological mechanisms induced by TRPM2 ion channels activation in renal ischemia-reperfusion injury. Mol. Biol. Rep. 49, 11071–11079 (2022).
Nazıroğlu, M. et al. Albumin evokes Ca2+-induced cell oxidative stress and apoptosis through TRPM2 channel in renal collecting duct cells reduced by curcumin. Sci. Rep. 9, 12403 (2019).
Esarte Palomero, O., Larmore, M. & DeCaen, P. G. Polycystin channel complexes. Annu. Rev. Physiol. 85, 425–448 (2023).
Stocker, S. D. & Sullivan, J. B. Deletion of the transient receptor potential vanilloid 1 channel attenuates sympathoexcitation and hypertension and improves glomerular filtration rate in 2-kidney-1-clip rats. Hypertension 80, 1671–1682 (2023).
Kassmann, M. et al. Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney. Acta Physiol. 207, 546–564 (2013).
Wei, X. et al. Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes. Metabolism 105, 154182 (2020).
Gualdani, R. et al. Mechanical activation of TRPV4 channels controls albumin reabsorption by proximal tubule cells. Sci. Signal. 13, eabc6967 (2020).
Cabral, P. D., Capurro, C. & Garvin, J. L. TRPV4 mediates flow-induced increases in intracellular Ca in medullary thick ascending limbs. Acta Physiol. 214, 319–328 (2015).
Saez, F., Hong, N. J., Cabral, P. D. & Garvin, J. L. Stretch-induced increases in intracellular Ca stimulate thick ascending limb O2− production and are enhanced in Dahl salt-sensitive rats. Hypertension 75, 431–438 (2020).
Hong, N. J., Gonzalez-Vicente, A., Saez, F. & Garvin, J. L. Mechanisms of decreased tubular flow-induced nitric oxide in Dahl salt-sensitive rat thick ascending limbs. Am. J. Physiol. Renal Physiol. 321, F369–F377 (2021).
Mamenko, M. V. et al. The renal TRPV4 channel is essential for adaptation to increased dietary potassium. Kidney Int. 91, 1398–1409 (2017).
Stavniichuk, A. et al. TRPV4 expression in the renal tubule is necessary for maintaining whole body K+ homeostasis. Am. J. Physiol. Renal Physiol. 324, F603–F616 (2023).
Mannaa, M. et al. Transient receptor potential vanilloid 4 channel deficiency aggravates tubular damage after acute renal ischaemia reperfusion. Sci. Rep. 8, 4878 (2018).
Alexander, R. T. et al. Ultrastructural and immunohistochemical localization of plasma membrane Ca2+-ATPase 4 in Ca2+-transporting epithelia. Am. J. Physiol. Renal Physiol. 309, F604–F616 (2015).
Hoenderop, J. G. et al. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J. Clin. Invest. 112, 1906–1914 (2003).
Peng, J. B., Suzuki, Y., Gyimesi, G. & Hediger, M. A. in: J. A. Kozak & J. W. Putney, Jr. (eds) Calcium Entry Channels in Non-Excitable Cells. 241–274 (CRC Press/Taylor & Francis, 2018).
Vennekens, R. et al. Permeation and gating properties of the novel epithelial Ca2+ channel. J. Biol. Chem. 275, 3963–3969 (2000).
Zuidscherwoude, M. et al. Functional basis for calmodulation of the TRPV5 calcium channel. J. Physiol. 601, 859–878 (2023).
van der Wijst, J., van Goor, M. K., Schreuder, M. F. & Hoenderop, J. G. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis. Kidney Int. 96, 1283–1291 (2019).
Dang, S. et al. Structural insight into TRPV5 channel function and modulation. Proc. Natl Acad. Sci. USA 116, 8869–8878 (2019).
Hughes, T. E. T. et al. Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EM. Nat. Struct. Mol. Biol. 25, 53–60 (2018).
Hughes, T. E. T. et al. Structural insights on TRPV5 gating by endogenous modulators. Nat. Commun. 9, 4198 (2018).
Hoenderop, J. G. et al. Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. EMBO J. 22, 776–785 (2003).
Khattar, V., Wang, L. & Peng, J. B. Calcium selective channel TRPV6: structure, function, and implications in health and disease. Gene 817, 146192 (2022).
Wartenberg, P. et al. Additional data for the mouse TRPV6 expression atlas. Data Brief. 42, 108201 (2022).
Vallon, V., Unwin, R., Inscho, E. W., Leipziger, J. & Kishore, B. K. Extracellular nucleotides and P2 receptors in renal function. Physiol. Rev. 100, 211–269 (2020).
Palygin, O., Evans, L. C., Cowley, A. W. Jr. & Staruschenko, A. Acute in vivo analysis of ATP release in rat kidneys in response to changes of renal perfusion pressure. J. Am. Heart Assoc. 6, e006658 (2017).
Roshanravan, H. & Dryer, S. E. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species. Am. J. Physiol. Renal Physiol. 306, F1088–F1097 (2014).
Ilatovskaya, D. V., Palygin, O., Levchenko, V. & Staruschenko, A. Pharmacological characterization of the P2 receptors profile in the podocytes of the freshly isolated rat glomeruli. Am. J. Physiol. Cell Physiol. 305, C1050–C1059 (2013).
Palygin, O. et al. Characterization of purinergic receptor 2 signaling in podocytes from diabetic kidneys. iScience 24, 102528 (2021).
Arkhipov, S. N., Potter, D. L., Geurts, A. M. & Pavlov, T. S. Knockout of P2rx7 purinergic receptor attenuates cyst growth in a rat model of ARPKD. Am. J. Physiol. Renal Physiol. 317, F1649–f1655 (2019).
Chang, M. Y. et al. Inhibition of the P2X7 receptor reduces cystogenesis in PKD. J. Am. Soc. Nephrol. 22, 1696–1706 (2011).
Chaudhari, S., Mallet, R. T., Shotorbani, P. Y., Tao, Y. & Ma, R. Store-operated calcium entry: pivotal roles in renal physiology and pathophysiology. Exp. Biol. Med. 246, 305–316 (2021).
Park, S. J., Li, C. & Chen, Y. M. Endoplasmic reticulum calcium homeostasis in kidney disease: pathogenesis and therapeutic targets. Am. J. Pathol. 191, 256–265 (2021).
Monkawa, T. et al. Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney. Kidney Int. 53, 296–301 (1998).
Woll, K. A. & Van Petegem, F. Calcium-release channels: structure and function of IP3 receptors and ryanodine receptors. Physiol. Rev. 102, 209–268 (2022).
Tao, Y. et al. Enhanced Orai1-mediated store-operated Ca2+ channel/calpain signaling contributes to high glucose-induced podocyte injury. J. Biol. Chem. 298, 101990 (2022).
Gusev, K. et al. Reorganization and suppression of store-operated calcium entry in podocytes of type 2 diabetic rats. Int. J. Mol. Sci. 24, 7259 (2023).
Xu, S. et al. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis. 6, e1976 (2015).
Park, S. J. et al. Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome. Proc. Natl Acad. Sci. USA 116, 14154–14163 (2019).
Tao, Y., Mallet, R. T., Mathis, K. W. & Ma, R. Store-operated Ca2+ channel signaling: novel mechanism for podocyte injury in kidney disease. Exp. Biol. Med. 248, 425–433 (2023).
DeHaven, W. I. et al. TRPC channels function independently of STIM1 and Orai1. J. Physiol. 587, 2275–2298 (2009).
Tao, Y., Yazdizadeh Shotorbani, P., Inman, D., Das-Earl, P. & Ma, R. Store-operated Ca2+ entry inhibition ameliorates high glucose and ANG II-induced podocyte apoptosis and mitochondrial damage. Am. J. Physiol. Renal Physiol. 324, F494–F504 (2023).
Jin, J., Ye, M., Hu, K., Gong, J. & He, Q. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy. Histol. Histopathol. 34, 671–682 (2019).
Menè, P., Teti, A., Pugliese, F. & Cinotti, G. A. Calcium release-activated calcium influx in cultured human mesangial cells. Kidney Int. 46, 122–128 (1994).
Ma, R., Smith, S., Child, A., Carmines, P. K. & Sansom, S. C. Store-operated Ca2+ channels in human glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 278, F954–F961 (2000).
Sours-Brothers, S., Ding, M., Graham, S. & Ma, R. Interaction between TRPC1/TRPC4 assembly and STIM1 contributes to store-operated Ca2+ entry in mesangial cells. Exp. Biol. Med. 234, 673–682 (2009).
Wu, P. et al. Store-operated Ca2+ channels in mesangial cells inhibit matrix protein expression. J. Am. Soc. Nephrol. 26, 2691–2702 (2015).
Mai, X. et al. Blockade of Orai1 store-operated calcium entry protects against renal fibrosis. J. Am. Soc. Nephrol. 27, 3063–3078 (2016).
Zeng, B. et al. ORAI channels are critical for receptor-mediated endocytosis of albumin. Nat. Commun. 8, 1920 (2017).
Woodward, O. M. et al. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1. PLoS One 5, e12305 (2010).
Yanda, M. K., Liu, Q., Cebotaru, V., Guggino, W. B. & Cebotaru, L. Role of calcium in adult onset polycystic kidney disease. Cell Signal. 53, 140–150 (2019).
Mamenko, M. et al. Defective store-operated calcium entry causes partial nephrogenic diabetes insipidus. J. Am. Soc. Nephrol. 27, 2035–2048 (2016).
Kuo, I. Y. et al. Cyst formation following disruption of intracellular calcium signaling. Proc. Natl Acad. Sci. USA 111, 14283–14288 (2014).
Padhy, B., Xie, J., Wang, R., Lin, F. & Huang, C. L. Channel function of polycystin-2 in the endoplasmic reticulum protects against autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 33, 1501–1516 (2022).
Anyatonwu, G. I., Estrada, M., Tian, X., Somlo, S. & Ehrlich, B. E. Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2. Proc. Natl Acad. Sci. USA 104, 6454–6459 (2007).
Li, Y. et al. Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. J. Biol. Chem. 284, 36431–36441 (2009).
Sammels, E. et al. Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J. Biol. Chem. 285, 18794–18805 (2010).
Mekahli, D. et al. Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium 51, 452–458 (2012).
Cárdenas, C. et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142, 270–283 (2010).
Kuo, I. Y. et al. Polycystin 2 regulates mitochondrial Ca2+ signaling, bioenergetics, and dynamics through mitofusin 2. Sci. Signal. 12, eaat7397 (2019).
Padovano, V. et al. The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function. Mol. Biol. Cell 28, 261–269 (2017).
Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488–493 (2013).
Chiaravalli, M. et al. 2-Deoxy-D-glucose ameliorates PKD progression. J. Am. Soc. Nephrol. 27, 1958–1969 (2016).
Padovano, V., Podrini, C., Boletta, A. & Caplan, M. J. Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat. Rev. Nephrol. 14, 678–687 (2018).
Giorgi, C., Marchi, S. & Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol. 19, 713–730 (2018).
Su, L., Zhang, J., Gomez, H., Kellum, J. A. & Peng, Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy 19, 401–414 (2023).
Babcock, D. F., Herrington, J., Goodwin, P. C., Park, Y. B. & Hille, B. Mitochondrial participation in the intracellular Ca2+ network. J. Cell Biol. 136, 833–844 (1997).
Garbincius, J. F. & Elrod, J. W. Mitochondrial calcium exchange in physiology and disease. Physiol. Rev. 102, 893–992 (2022).
Yuan, Z. et al. Calcium uptake via mitochondrial uniporter contributes to palmitic acid-induced apoptosis in mouse podocytes. J. Cell Biochem. 118, 2809–2818 (2017).
Xu, H. et al. IP3R-Grp75-VDAC1-MCU calcium regulation axis antagonists protect podocytes from apoptosis and decrease proteinuria in an adriamycin nephropathy rat model. BMC Nephrol. 19, 140 (2018).
Yanda, M. K., Tomar, V., Cole, R., Guggino, W. B. & Cebotaru, L. The mitochondrial Ca2+ import complex is altered in ADPKD. Cell Calcium 101, 102501 (2022).
Thai, T. L. et al. The polarized effect of intracellular calcium on the renal epithelial sodium channel occurs as a result of subcellular calcium signaling domains maintained by mitochondria. J. Biol. Chem. 290, 28805–28811 (2015).
de Groot, T. et al. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation. J. Am. Soc. Nephrol. 20, 1693–1704 (2009).
Fluck, E. C., Yazici, A. T., Rohacs, T. & Moiseenkova-Bell, V. Y. Structural basis of TRPV5 regulation by physiological and pathophysiological modulators. Cell Rep. 39, 110737 (2022).
Bindels, R. J., Hartog, A., Timmermans, J. & Van Os, C. H. Active Ca2+ transport in primary cultures of rabbit kidney CCD: stimulation by 1,25-dihydroxyvitamin D3 and PTH. Am. J. Physiol. 261, F799–F807 (1991).
Hoenderop, J. G. et al. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1α-hydroxylase knockout mice. FASEB J. 16, 1398–1406 (2002).
van Megen, W. H., Tan, R. S. G., Alexander, R. T. & Dimke, H. Differential parathyroid and kidney Ca2+-sensing receptor activation in autosomal dominant hypocalcemia 1. EBioMedicine 78, 103947 (2022).
Bustamante, M. et al. Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism. J. Am. Soc. Nephrol. 19, 109–116 (2008).
Sands, J. M. et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J. Clin. Invest. 99, 1399–1405 (1997).
Loupy, A. et al. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor. J. Clin. Invest. 122, 3355–3367 (2012).
Tan, R. S. G., Lee, C. H. L., Dimke, H. & Todd Alexander, R. The role of calcium-sensing receptor signaling in regulating transepithelial calcium transport. Exp. Biol. Med. 246, 2407–2419 (2021).
Blankenship, K. A. et al. The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMCA. Am. J. Physiol. Renal Physiol. 280, F815–F822 (2001).
Topala, C. N. et al. Activation of the Ca2+-sensing receptor stimulates the activity of the epithelial Ca2+ channel TRPV5. Cell Calcium 45, 331–339 (2009).
Gong, Y. et al. Claudin-14 regulates renal Ca2+ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J. 31, 1999–2012 (2012).
Gong, Y. & Hou, J. Claudin-14 underlies Ca2+-sensing receptor-mediated Ca2+ metabolism via NFAT-microRNA-based mechanisms. J. Am. Soc. Nephrol. 25, 745–760 (2014).
Lee, J. J. et al. Activation of the calcium sensing receptor increases claudin-14 expression via a PLC–p38–Sp1 pathway. FASEB J. 35, e21982 (2021).
Capasso, G. et al. The calcium sensing receptor modulates fluid reabsorption and acid secretion in the proximal tubule. Kidney Int. 84, 277–284 (2013).
Ward, D. T., McLarnon, S. J. & Riccardi, D. Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J. Am. Soc. Nephrol. 13, 1481–1489 (2002).
Picard, N. et al. Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch. 460, 677–687 (2010).
Segawa, H. et al. Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter. Am. J. Physiol. Renal Physiol. 292, F395–F403 (2007).
Alexander, R. T. & Dimke, H. Effects of parathyroid hormone on renal tubular calcium and phosphate handling. Acta Physiol. 238, e13959 (2023).
Duan, Y., Weinstein, A. M., Weinbaum, S. & Wang, T. Shear stress-induced changes of membrane transporter localization and expression in mouse proximal tubule cells. Proc. Natl Acad. Sci. USA 107, 21860–21865 (2010).
Du, Z., Weinbaum, S., Weinstein, A. M. & Wang, T. Regulation of glomerulotubular balance. III. Implication of cytosolic calcium in flow-dependent proximal tubule transport. Am. J. Physiol. Renal Physiol. 308, F839–F847 (2015).
Churchill, P. C. Second messengers in renin secretion. Am. J. Physiol. 249, F175–F184 (1985).
Beierwaltes, W. H. The role of calcium in the regulation of renin secretion. Am. J. Physiol. Renal Physiol. 298, F1–F11 (2010).
Lara, L. S., Gonzalez, A. A., Hennrikus, M. T. & Prieto, M. C. Hormone-dependent regulation of renin and effects on prorenin receptor signaling in the collecting duct. Curr. Hypertens. Rev. 18, 91–100 (2022).
Chebib, F. T., Sussman, C. R., Wang, X., Harris, P. C. & Torres, V. E. Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat. Rev. Nephrol. 11, 451–464 (2015).
Star, R. A., Nonoguchi, H., Balaban, R. & Knepper, M. A. Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J. Clin. Invest. 81, 1879–1888 (1988).
Lanktree, M. B. et al. Prevalence estimates of polycystic kidney and liver disease by population sequencing. J. Am. Soc. Nephrol. 29, 2593–2600 (2018).
Márquez-Nogueras, K. M., Vuchkovska, V. & Kuo, I. Y. Calcium signaling in polycystic kidney disease — cell death and survival. Cell Calcium 112, 102733 (2023).
Liu, X. et al. Polycystin-2 is an essential ion channel subunit in the primary cilium of the renal collecting duct epithelium. eLife 7, e33183 (2018).
Ha, K. et al. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus. eLife 9, e.60684 (2020).
Kim, S. et al. The polycystin complex mediates Wnt/Ca2+ signalling. Nat. Cell Biol. 18, 752–764 (2016).
Kleene, S. J. & Kleene, N. K. The native TRPP2-dependent channel of murine renal primary cilia. Am. J. Physiol. Renal Physiol. 312, F96–F108 (2017).
Su, Q. et al. Structure of the human PKD1-PKD2 complex. Science 361, eaat9819 (2018).
Marquez-Nogueras, K. M. & Kuo, I. Y. Cardiovascular perspectives of the TRP channel polycystin 2. J. Physiol. https://doi.org/10.1113/JP283835 (2023).
Grieben, M. et al. Structure of the polycystic kidney disease TRP channel polycystin-2 (PC2). Nat. Struct. Mol. Biol. 24, 114–122 (2017).
Shen, P. S. et al. The structure of the polycystic kidney disease channel PKD2 in lipid nanodiscs. Cell 167, 763–773.e711 (2016).
Kwon, M. et al. G-protein signaling modulator 1 deficiency accelerates cystic disease in an orthologous mouse model of autosomal dominant polycystic kidney disease. Proc. Natl Acad. Sci. USA 109, 21462–21467 (2012).
Hu, J. & Harris, P. C. Regulation of polycystin expression, maturation and trafficking. Cell Signal. 72, 109630 (2020).
Ta, C. M., Vien, T. N., Ng, L. C. T. & DeCaen, P. G. Structure and function of polycystin channels in primary cilia. Cell Signal. 72, 109626 (2020).
Douguet, D., Patel, A. & Honoré, E. Structure and function of polycystins: insights into polycystic kidney disease. Nat. Rev. Nephrol. 15, 412–422 (2019).
Praetorius, H. A. & Spring, K. R. A physiological view of the primary cilium. Annu. Rev. Physiol. 67, 515–529 (2005).
Kleene, S. J. & Kleene, N. K. Inward Ca2+ current through the polycystin-2-dependent channels of renal primary cilia. Am. J. Physiol. Renal Physiol. 320, F1165–F1173 (2021).
Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129–137 (2003).
Delling, M., DeCaen, P. G., Doerner, J. F., Febvay, S. & Clapham, D. E. Primary cilia are specialized calcium signalling organelles. Nature 504, 311–314 (2013).
Bai, C. X. et al. Activation of TRPP2 through mDia1-dependent voltage gating. EMBO J. 27, 1345–1356 (2008).
Padovano, V., Mistry, K., Merrick, D., Gresko, N. & Caplan, M. J. A cut above (and below): protein cleavage in the regulation of polycystin trafficking and signaling. Cell Signal. 72, 109634 (2020).
Qian, F. et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl Acad. Sci. USA 99, 16981–16986 (2002).
Arif Pavel, M. et al. Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutant. Proc. Natl Acad. Sci. USA 113, E2363–E2372 (2016).
Wang, Z. et al. The ion channel function of polycystin-1 in the polycystin-1/polycystin-2 complex. EMBO Rep. 20, e48336 (2019).
Wang, X. et al. TRPC5 does not cause or aggravate glomerular disease. J. Am. Soc. Nephrol. 29, 409–415 (2018).
Brown, B. J., Boekell, K. L., Stotter, B. R., Talbot, B. E. & Schlondorff, J. S. Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models. PLoS One 17, e0272313 (2022).
Riehle, M. et al. TRPC6 G757D loss-of-function mutation associates with FSGS. J. Am. Soc. Nephrol. 27, 2771–2783 (2016).
Anderson, M., Kim, E. Y., Hagmann, H., Benzing, T. & Dryer, S. E. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol. Am. J. Physiol. Cell Physiol. 305, C276–C289 (2013).
Saqib, U. et al. Transient receptor potential canonical 6 (TRPC6) channel in the pathogenesis of diseases: a jack of many trades. Inflammation 46, 1144–1160 (2023).
Bai, Y. et al. Structural basis for pharmacological modulation of the TRPC6 channel. eLife 9, e.53311 (2020).
Lin, B. L. et al. Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy. JCI Insight 7, e158906 (2022).
Lin, B. L. et al. In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease. Proc. Natl Acad. Sci. USA 116, 10156–10161 (2019).
Trachtman, H. et al. TRPC6 inhibitor BI 764198 in focal segmental glomerulosclerosis: phase 2 study design. Kidney Int. Rep. 8, 2822–2825 (2023).
Spires, D. et al. Protective role of Trpc6 knockout in the progression of diabetic kidney disease. Am. J. Physiol. Renal Physiol. 315, F1091–F1097 (2018).
Ilatovskaya, D. V. et al. A NOX4/TRPC6 pathway in podocyte calcium regulation and renal damage in diabetic kidney disease. J. Am. Soc. Nephrol. 29, 1917–1927 (2018).
Ilatovskaya, D. V. et al. Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels. Sci. Rep. 5, 17637 (2015).
Bohovyk, R. et al. Protease-activated receptor 1-mediated damage of podocytes in diabetic nephropathy. Diabetes 72, 1795–1808 (2023).
Wang, Z. et al. Transient receptor potential cation channel 6 contributes to kidney injury induced by diabetes and hypertension. Am. J. Physiol. Renal Physiol. 322, F76–F88 (2022).
Palygin, O. The role of TRPC6 channel in chronic kidney disease. Am. J. Physiol. Renal Physiol. 322, F195–F196 (2022).
Golosova, D. et al. Role of opioid signaling in kidney damage during the development of salt-induced hypertension. Life Sci. Alliance 3, e202000853 (2020).
Kim, E. Y. & Dryer, S. E. Effects of TRPC6 inactivation on glomerulosclerosis and renal fibrosis in aging rats. Cells 10, 856 (2021).
Kim, E. Y., Yazdizadeh Shotorbani, P. & Dryer, S. E. TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions. Biochem. Biophys. Rep. 17, 139–150 (2019).
Ilatovskaya, D. V. et al. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli. Kidney Int. 86, 506–514 (2014).
Binz-Lotter, J. et al. Injured podocytes are sensitized to angiotensin II-induced calcium signaling. J. Am. Soc. Nephrol. 31, 532–542 (2020).
Semenikhina, M. et al. β-Arrestin pathway activation by selective ATR1 agonism promotes calcium influx in podocytes, leading to glomerular damage. Clin. Sci. 137, 1789–1804 (2023).
Pavlov, T. S. et al. NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease. FASEB J. 34, 13396–13408 (2020).
Anderson, M., Roshanravan, H., Khine, J. & Dryer, S. E. Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species. J. Cell Physiol. 229, 434–442 (2014).
Salemkour, Y. et al. Podocyte injury in diabetic kidney disease in mouse models involves TRPC6-mediated calpain activation impairing autophagy. J. Am. Soc. Nephrol. 34, 1823–1842 (2023).
May, C. J. et al. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events. Kidney Int. 104, 265–278 (2023).
Shalygin, A. et al. Cytoskeleton rearrangements modulate TRPC6 channel activity in podocytes. Int. J. Mol. Sci. 22, 4396 (2021).
Renkema, K. Y. et al. TRPV5 gene polymorphisms in renal hypercalciuria. Nephrol. Dial. Transpl. 24, 1919–1924 (2009).
Knauf, F. et al. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int. 84, 895–901 (2013).
Mulay, S. R. et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J. Clin. Invest. 123, 236–246 (2013).
Shroff, U. N., Schiessl, I. M., Gyarmati, G., Riquier-Brison, A. & Peti-Peterdi, J. Novel fluorescence techniques to quantitate renal cell biology. Methods Cell Biol. 154, 85–107 (2019).
Nguyen, V. V. T. et al. A systematic review of kidney-on-a-chip-based models to study human renal (patho-)physiology. Dis. Model. Mech. 16, dmm050113 (2023).
Shi, M. et al. Human ureteric bud organoids recapitulate branching morphogenesis and differentiate into functional collecting duct cell types. Nat. Biotechnol. 41, 252–261 (2023).
Zeng, Z. et al. Generation of patterned kidney organoids that recapitulate the adult kidney collecting duct system from expandable ureteric bud progenitors. Nat. Commun. 12, 3641 (2021).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41581-024-00835-z